Actelion reports stronger-than-expected switch from Tracleer into Opsumit in NRx in the US

BUY, Fair Value CHF75 (-6%)

News published on January Tuesday 14, 2014
Share on

The Essentials

Everything you need to know about investment banking dedicated to growth
Stay Informed
Get our news
Join our Team
Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels
Explore our opportunities